Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma – Genetic Engineering News

Revalesio to Present Research on the Anti-Inflammatory Effects of RNS60 in Asthma
Genetic Engineering News
Revalesio Corporation announced today that research related to the use of RNS60, its novel anti-inflammatory, will be featured in two poster presentations at the Annual Meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) in San

and more »

View full post on asthma – Google News

Palatin Obtains $21.1M to Advance Programs in Female Sexual Dysfunction and Asthma – Genetic Engineering News

Palatin Obtains $21.1M to Advance Programs in Female Sexual Dysfunction and Asthma
Genetic Engineering News
It intends to use the proceeds for working capital and general corporate purposes including its clinical trial program with bremelanotide for female sexual dysfunction (FSD), its PL-3994 programs for asthma, and for the preclinical development of

View full post on asthma – Google News